MRPS35 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.656200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.365420E-01
Normal-vs-Stage2
2.831400E-01
Normal-vs-Stage3
8.657000E-01
Normal-vs-Stage4
1.196190E-01
Stage1-vs-Stage2
8.850200E-01
Stage1-vs-Stage3
2.738800E-01
Stage1-vs-Stage4
1.872590E-01
Stage2-vs-Stage3
3.084000E-01
Stage2-vs-Stage4
5.801800E-02
Stage3-vs-Stage4
1.273620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.826200E-01
Normal-vs-AfricanAmerican
2.788400E-01
Normal-vs-Asian
1.642600E-01
Caucasian-vs-AfricanAmerican
9.562200E-01
Caucasian-vs-Asian
7.092800E-01
AfricanAmerican-vs-Asian
7.433600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.802400E-01
Normal-vs-Female
2.379200E-01
Male-vs-Female
3.552000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.927600E-01
Normal-vs-Age(41-60Yrs)
1.689440E-01
Normal-vs-Age(61-80Yrs)
3.458400E-01
Normal-vs-Age(81-100Yrs)
1.672400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.512400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.510600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.506000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.507600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.245800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.851800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.651400E-01
Normal-vs-Daily Drinker
4.139400E-01
Normal-vs-Weekly Drinker
5.374600E-01
Normal-vs-Occasional Drinker
3.422300E-02
Normal-vs-Social Drinker
2.686000E-01
Non Drinker-vs-Daily Drinker
4.936400E-01
Non Drinker-vs-Weekly Drinker
6.967600E-01
Non Drinker-vs-Occasional Drinker
6.032400E-02
Non Drinker-vs-Social Drinker
7.969600E-01
Daily Drinker-vs-Weekly Drinker
4.225000E-01
Daily Drinker-vs-Occasional Drinker
5.284800E-01
Daily Drinker-vs-Social Drinker
3.804400E-01
Weekly Drinker-vs-Occasional Drinker
5.287800E-02
Weekly Drinker-vs-Social Drinker
8.651400E-01
Occasional Drinker-vs-Social Drinker
2.398300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.589600E-02
Normal-vs-Grade 2
2.845800E-02
Normal-vs-Grade 3
6.778000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.678800E-01
Grade 1-vs-Grade 3
4.002200E-01
Grade 1-vs-Grade 4
5.589600E-02
Grade 2-vs-Grade 3
1.658630E-01
Grade 2-vs-Grade 4
2.845800E-02
Grade 3-vs-Grade 4
6.778000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.937200E-01
Normal-vs-NonDiabetic
2.419600E-01
Diabetic-vs-NonDiabetic
4.156100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.646400E-01
Normal-vs-NoPancreatitis
3.057000E-01
Pancreatitis-vs-NoPancreatitis
7.715800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.623350E-01
Normal-vs-N1
3.182400E-01
N0-vs-N1
5.125400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.076300E-02
Normal-vs-TP53-NonMutant
2.438000E-01
TP53-Mutant-vs-TP53-NonMutant
7.282300E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
